Uploaded October 2025 | Updated September 2026, 2 weeks ago
Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical Cannabis, where he uses his extensive background in biotechnology research and cannabinoid research to educate cannabis and biotechnology professionals and infuse the industry with science-backed legitimacy.
In addition to serving as a Program Director for the Morehouse School of Medicine and teaching graduate students, Hemant also serves as a Scientific Advisor for Essentia Scientific, a company that delivers an array of cannabinoid product solutions, including acidic cannabinoids, with their patented water-as-solvent extraction technology.
During our conversation, we discuss:
* What are cannabinoid acids and how do they differ from the neutral cannabinoids
* Why have cannabinoid acids been traditionally overlooked in research and consumer products
* How THCA produces different effects than THC
* Why CBDA is more bioavailable and more potent than CBD
* How new extraction and stabilization techniques are helping make cannabinoids acids more accessible
* and more
Thanks to This Episode’s Sponsor: CANN
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.
Additional Resources
* Essentia Scientific Website - essentiascientific.com
* Email Hemant – Hibid@msm.edu
* Submit Your Abstract for CannMed 26 - cannmedevents.com/apply
* Meet the CannMed 26 Advisory Board - cannmedevents.com/speakers
Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical Cannabis, where he uses his extensive background in biotechnology research and cannabinoid research to educate cannabis and biotechnology professionals and infuse the industry with science-backed legitimacy.
In addition to serving as a Program Director for the Morehouse School of Medicine and teaching graduate students, Hemant also serves as a Scientific Advisor for Essentia Scientific, a company that delivers an array of cannabinoid product solutions, including acidic cannabinoids, with their patented water-as-solvent extraction technology.
During our conversation, we discuss:
* What are cannabinoid acids and how do they differ from the neutral cannabinoids
* Why have cannabinoid acids been traditionally overlooked in research and consumer products
* How THCA produces different effects than THC
* Why CBDA is more bioavailable and more potent than CBD
* How new extraction and stabilization techniques are helping make cannabinoids acids more accessible
* and more
Thanks to This Episode’s Sponsor: CANN
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.
Additional Resources
* Essentia Scientific Website - essentiascientific.com
* Email Hemant – Hibid@msm.edu
* Submit Your Abstract for CannMed 26 - cannmedevents.com/apply
* Meet the CannMed 26 Advisory Board - cannmedevents.com/speakers
![Cannabinoid Hyperemesis Syndrome: Smoking Vs. Vaping
#shorts #chs #cannabinoidhyperemesissyndrome
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ Cannabinoid Hyperemesis Syndrome: Smoking Vs. Vaping](https://i.ytimg.com/vi/cdTJ-kcG_rM/mqdefault.jpg)









